Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Placenta. 2020 Mar 6;93:113–118. doi: 10.1016/j.placenta.2020.03.004

Table 2.

Placental diffusion metrics across healthy and high-risk pregnancies

Control (n=97) FGR (n=36) p-valuea
Small Scale Diffusion (D) 1.76 1.74 0.76
Large Scale Pseudo-Diffusion (D*) 36.80 34.14 0.42
Perfusion Fraction (f, %) 40.65 37.68 0.19
Control (n=97) Early-Onset FGR (n=11) Late-Onset FGR (n=25) p-valueb
Small Scale Diffusion (D) 1.76 1.50 1.87c, d <0.05 c,d
Large Scale Pseudo-Diffusion (D*) 36.80 23.56 39.42d <0.05 d
Perfusion Fraction (f, %) 40.65 45.94 34.13c, d <0.05 c,d
Control (n=97) FGR, CPR >1 (n=21) FGR, CPR <1 (n=15) p-valueb
Small Scale Diffusion (D) 1.76 1.82 1.66 NS
Large Scale Pseudo-Diffusion (D*) 36.80 37.51 29.23 NS
Perfusion Fraction (f, %) 40.65 37.60 38.51 NS
Control (n=97) FGR, No MHD (n=31) FGR, + MHD (n=05) p-valueb
Small Scale Diffusion (D) 1.76 1.79 1.50 NS
Large Scale Pseudo-Diffusion (D*) 36.80 35.60 23.07 NS
Perfusion Fraction (f, %) 40.65 37.33 41.90 NS
a

Based on independent samples t-test

b

Pairwise comparisons based on least squares means estimates from ANOVA

c

significantly different from control at p < 0.05

d

significantly different from early-onset FGR at p < 0.05

Abbreviations: FGR=fetal growth restriction, CPR=cerebroplacental ratio, MHD=maternal hypertensive disorders (namely, gestational hypertension, chronic hypertension and preeclampsia)